|
|
|
|
| LEADER |
01311nam a2200301Ia 4500 |
| 001 |
10.3390-children9070993 |
| 008 |
220718s2022 CNT 000 0 und d |
| 020 |
|
|
|a 22279067 (ISSN)
|
| 245 |
1 |
0 |
|a Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
|
| 260 |
|
0 |
|b MDPI
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3390/children9070993
|
| 520 |
3 |
|
|a At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
|
| 650 |
0 |
4 |
|a adverse event
|
| 650 |
0 |
4 |
|a children
|
| 650 |
0 |
4 |
|a lymphadenopathy
|
| 650 |
0 |
4 |
|a SARS-CoV-2
|
| 650 |
0 |
4 |
|a vaccine
|
| 700 |
1 |
|
|a Bloise, S.
|e author
|
| 700 |
1 |
|
|a Del Giudice, E.
|e author
|
| 700 |
1 |
|
|a Lubrano, R.
|e author
|
| 700 |
1 |
|
|a Marcellino, A.
|e author
|
| 700 |
1 |
|
|a Martucci, V.
|e author
|
| 700 |
1 |
|
|a Sanseviero, M.
|e author
|
| 700 |
1 |
|
|a Sermoneta, D.
|e author
|
| 700 |
1 |
|
|a Spatuzzo, M.
|e author
|
| 700 |
1 |
|
|a Testa, A.
|e author
|
| 700 |
1 |
|
|a Ventriglia, F.
|e author
|
| 773 |
|
|
|t Children
|
